- Emergent BioSolutions (EBS) said CFO Richard Lindahl will retire effective Dec. 31, 2026.
- Frank Vargo, the company’s vice president and treasurer, will become interim CFO on Jan. 1, 2027.
- Lindahl will serve as a senior executive advisor from Jan. 1 through March 31, 2027, to support the transition.
- EBS shares fell -4.6% premarket.
Emergent BioSolutions CFO Richard Lindahl to retire, Frank Vargo named interim CFO (EBS:NYSE)
